« Back to Record
Citation APA

Chiritescu, G., Dumon, K., Verslype, C., Houbiers, G., Peeters, M., Janssens, J., Van Daele, D., Laurent, S., Arts, J., Hendrickx, K., Borbath, I., Ferrante, M., Bastin, F., Goeminne, J. C., Van Laethem, J.-L., Vanderstraeten, E., Decaestecker, J., Van Vaerenbergh, W., Delhougne, B., & Van Cutsem, E. (2018). Final results of a phase II quality of life (QOL) randomized, cross-over (CO) study with gemcitabine (Gem) and nab-paclitaxel (n-P) in locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC): QOLINPAC. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 29, viii252. doi:10.1093/annonc/mdy282.123


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/307363

Chiritescu, G., Dumon, K., Verslype, C., Houbiers, G., Peeters, M., Janssens, J., Van Daele, D., Laurent, S., Arts, J., Hendrickx, K., Borbath, I., Ferrante, M., Bastin, F., Goeminne, J. C., Van Laethem, J.-L., Vanderstraeten, E., Decaestecker, J., Van Vaerenbergh, W., Delhougne, B., & Van Cutsem, E. (2018). Final results of a phase II quality of life (QOL) randomized, cross-over (CO) study with gemcitabine (Gem) and nab-paclitaxel (n-P) in locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC): QOLINPAC. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 29, viii252. doi:10.1093/annonc/mdy282.123